Whereas trametinib treatment resulted in the highest density of CD103+CD8+ TRM cells at the tumor margin for patient 16, the accumulation of these TRM cells occurred both at the margin and within the tumor from patient 8 (Figure 5E). The gene discussed is CD8A; the disease is neoplasm.